Prescription weight- loss drugs: Can they help you? Prescription weight- loss drugs. Examine the pros and cons of medications to treat obesity. By Mayo Clinic Staff. If you have serious health problems because of your weight — and lifestyle changes haven't resulted in significant weight loss — prescription weight- loss drugs may be an option. You should know, though, that prescription weight- loss drugs don't replace the need to make healthy changes in your eating habits and activity level. Who is a candidate for weight- loss drugs? Prescription weight- loss drugs are generally reserved for people who haven't been able to lose weight through diet and exercise, and who have health problems because of their weight. They're not for people who want to lose just a few pounds for cosmetic reasons. Your doctor may consider weight- loss drugs for you if you haven't been able to lose weight through diet and exercise and you meet one of the following: Your body mass index (BMI) is greater than 3. Your BMI is greater than 2. Before selecting a medication for you, your doctor will consider your health history, the possible side effects of the medications and any potential interaction of weight- loss drugs with other medications you're taking. How well do weight- loss drugs work? When combined with a low- calorie diet and regular exercise, weight- loss drugs produce an average weight loss of 5 to 1. Diet and exercise are responsible for part of this weight loss, and medications are responsible for part as well. Losing 5 to 1. 0 percent of your total weight may not seem like much, but even modest weight loss can improve your health by: Decreasing blood pressure. Decreasing lipid levels. Decreasing blood glucose levels. Increasing insulin sensitivity. It's important to keep in mind, however, that these medications may not work for everyone. And when you stop taking these medications, you're likely to regain much or all of the weight you lost. April 3. 0, 2. 01. Ask. Mayo. Expert. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2. Bray GA, et al. Obesity in adults: Drug therapy. Padwal RS, et al. Drug treatments for obesity: Orlistat, sibutramine and remonabant. Rucker D, et al. Long term pharmacotherapy for obesity and overweight: Updated meta- analysis. Meridia (sibutramine): Market withdrawal due to risk of serious cardiovascular events. Food and Drug Administration. Accessed April 1. Completed safety review of Xenical/Alli (orlistat) and severe liver injury. Food and Drug Administration. Accessed April 1. Xenical (prescribing information). South San Francisco, Calif.: Genentech USA, Inc.; 2. Accessed April 1. Belviq (prescribing information). San Diego, Calif.: Arena Pharmaceuticals; 2. Accessed April 1. FDA approves Belviq to treat some overweight or obese adults. Food and Drug Administration. Accessed April 1. FDA approves weight- management drug Qsymia. Food and Drug Administration. Accessed April 1. Qsymia (prescribing information). Mountain View, Calif.: Vivus Inc.; 2. Accessed April 1. Best New Prescription Weight Loss Drug Lose Belly Fat . Best New Prescription Weight Loss Drug. To Lose Weight, Skip Dinner A Few Days A Week New research suggests that skipping dinner helps you burn more fat in the evening and may even help with weight loss. Best Prescription Weight Loss Drug Weight Loss Centers In Lawrenceville Ga Best Prescription Weight Loss Drug Cholesterol In Eggs Hdl Or Ldl 15 Days Water Fasting And Weight Loss. Best Prescription Weight Loss Drug Fat Burning Nutribullet Recipes Best Prescription Weight Loss Drug What Is My Fat Burning Target Heart Rate high.ldl.cholesterol.quizlet How Doe. Pollack A. FDA approves Qsymia, a weight- loss drug. Accessed April 1. Allison DB, et al. Controlled- release phentermine/topiramate in severely obese adults: A randomized controlled trial (EQUIP). Medications target long- term weight control. Food and Drug Administration. Accessed April 1. Publication in Federal Register tomorrow moves Belviq (lorcaserin) closer to launch. Accessed April 1. Didrex (prescribing information). New York., N. Y.: Pharmacia and Upjohn; 2. Accessed April 1.
Suprenza (prescribing information). Cranford, N. J.: Akrimas; 2. Accessed April 1. Tenuate (prescribing information). Parsippany, N. J.: Actavis Pharma, Inc., 2. Accessed April 1. Bontril (prescribing information). Princeton, N. J.: Sandoz Pharmaceuticals, 2. Accessed April 1. Contrave (prescribing information). Deerfield, Ill.: Takeda Pharmaceuticals America; 2. Accessed April 1. FDA approves weight- management drug Contrave. Food and Drug Administration. Accessed April 1. Apovian CM, et al. Guidelines on pharmacological management of obesity: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. FDA approves weight- management drug Saxenda. Food and Drug Administration. Accessed April 1. Saxenda (prescribing information). Plainsboro, N. J.: Novo Nordisk; 2. Accessed April 1. Murphy JA, et al. Drugs in perspective: Liraglutide for the treatment of obesity. Accessed April 1. See more In- depth.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
July 2017
Categories |